Literature DB >> 10960274

Mesalamine and relapse prevention in Crohn's disease.

M Cottone, C Cammà.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10960274     DOI： 10.1053/gast.2000.16153

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  12 in total

Review 1.  New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.

Authors:  M Campieri
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 2.  Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence.

Authors:  J P Achkar; B Shen
Journal:  Curr Gastroenterol Rep       Date:  2001-12

3.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  M J Carter; A J Lobo; S P L Travis
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 4.  Standards of medical treatment and nutrition in Crohn's disease.

Authors:  Britta Siegmund; Martin Zeitz
Journal:  Langenbecks Arch Surg       Date:  2004-09-23       Impact factor: 3.445

5.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

6.  Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

Authors:  Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 7.  Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

Authors:  A A van Bodegraven; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 8.  Postoperative Crohn's disease recurrence: a practical approach.

Authors:  Pilar Nos; Eugeni Domenech
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 9.  Alternative strategies for the use of infliximab in pediatric inflammatory bowel disease.

Authors:  Joel R Rosh
Journal:  Curr Gastroenterol Rep       Date:  2008-06

10.  ACG Clinical Guideline: Management of Crohn's Disease in Adults.

Authors:  Gary R Lichtenstein; Edward V Loftus; Kim L Isaacs; Miguel D Regueiro; Lauren B Gerson; Bruce E Sands
Journal:  Am J Gastroenterol       Date:  2018-03-27       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.